Alexion Pharmaceuticals, Inc. (ALXN)

Elliott · 2020-05

arc beats above · slides in the middle · loops below · scroll → 1 LOOPS

Deck intelligence map

coverage by narrative range · generated from this deck JSON

Narrative range 6 total

Metadata

Components

Metrics

Tools

Frameworks

Beats

Loops

Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 18 hits

— 0/2 slides

50% 1/2 slides · 2 hits 100% 2/2 slides 100% 2/2 slides

— 0/2 slides

Agitate 2 slides 100% 2/2 slides 100% 2/2 slides · 15 hits

— 0/2 slides

100% 2/2 slides 100% 2/2 slides

— 0/2 slides

Solution 2 slides 100% 2/2 slides 100% 2/2 slides · 12 hits

— 0/2 slides

50% 1/2 slides 100% 2/2 slides 50% 1/2 slides

Slide inventory

every slide · same image gating as the playbook

This is a formal shareholder letter from Elliott Advisors to Alexion Pharmaceuticals, dated May 12, 2020.front_matter

Open slide detail

The slide uses a combination of a line chart for valuation erosion and bar charts for relative performance benchmarking.expose_gap

Open slide detailBeat · Problem

The slide uses a list of analyst quotes to frame the 'existential debate' and a table to quantify the impact of specific corporate missteps.preempt_rebuttal

Open slide detailBeat · Problem

Uses analyst quotes to highlight the gap between management's stated discipline and the market's perception of defensive, value-destroying M&A.expose_contradiction

Open slide detailBeat · Agitate

The slide uses external analyst quotes to build a case against management's M&A strategy.name_villain

Open slide detailBeat · Agitate

This is a text-heavy page from a shareholder letter, likely part of a larger argument regarding management performance.summarize

Open slide detail

The slide uses a scatter plot to demonstrate that Alexion is undervalued compared to its peers with similar growth profiles.expose_gap

Open slide detail

This is a page from a shareholder letter, likely from Elliott Management, arguing for a sale of Alexion.present_solution

Open slide detailLoop · Cost Of Inaction

This is a page from an activist investor letter (Elliott Management) to the Board of Alexion Pharmaceuticals.propose_solution

Open slide detailBeat · SolutionLoop · Cost Of Inaction

This is the final page of a formal activist investor letter.closing_ask

Open slide detailBeat · Solution